Literature DB >> 24982048

Viral, bacterial or both? Regardless, we need to treat infection in COPD.

Tobias Welte1, Marc Miravitlles2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24982048     DOI： 10.1183/09031936.00041914

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  Cigarette Smoke Triggers IL-33-associated Inflammation in a Model of Late-Stage Chronic Obstructive Pulmonary Disease.

Authors:  Jasmine H Lee; Kendra L Hailey; Steven A Vitorino; Patricia A Jennings; Timothy D Bigby; Ellen C Breen
Journal:  Am J Respir Cell Mol Biol       Date:  2019-11       Impact factor: 6.914

2.  Cigarette smoke-induced chronic obstructive pulmonary disease is attenuated by CCL20-blocker: a rat model.

Authors:  Desheng Sun; Yao Ouyang; Yanhui Gu; Xiansheng Liu
Journal:  Croat Med J       Date:  2016-08-31       Impact factor: 1.351

3.  Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study.

Authors:  Alexander J Mackay; Konstantinos Kostikas; Nicolas Roche; Stefan-Marian Frent; Petter Olsson; Pascal Pfister; Pritam Gupta; Francesco Patalano; Donald Banerji; Jadwiga A Wedzicha
Journal:  Respir Res       Date:  2020-04-22

4.  Pathogens Isolated and Their Association With the Long-Term Outcome in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  C Mohan Rao; Kinshuk Sarbhai; Saswat Subhankar; Amrut Mohapatra; Nipa Singh; Prem S Panda; Shubhransu Patro; Sanghamitra Pati
Journal:  Cureus       Date:  2022-06-21

Review 5.  The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable Haemophilus influenzae.

Authors:  Yu-Ching Su; Farshid Jalalvand; John Thegerström; Kristian Riesbeck
Journal:  Front Immunol       Date:  2018-11-05       Impact factor: 7.561

6.  Pneumonia in exacerbations of COPD: what is the clinical significance?

Authors:  Samuel P Trethewey; John R Hurst; Alice M Turner
Journal:  ERJ Open Res       Date:  2020-01-27

Review 7.  COVID-19 Susceptibility in chronic obstructive pulmonary disease.

Authors:  Jordi Olloquequi
Journal:  Eur J Clin Invest       Date:  2020-09-02       Impact factor: 5.722
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.